
|Articles|December 1, 2003
FDA trial for toric ICL addresses myopic astigmatism
Cincinnati, OH-Early results from an FDA clinical trial suggest that the toric implantable contact lens (ICL, STAAR Surgical) is extremely promising as a safe and effective alternative to LASIK for the correction of myopia with astigmatism, reported David Schneider, MD.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
ONL Therapeutics reports positive phase 1b data for xelafaslatide in geographic atrophy
2
Alcon raises offer in amended deal to acquire STAAR Surgical
3
Ocular Therapeutix accelerates NDA submission plans for AXPAXLI for wet AMD
4
Study maps thermal dynamics of glaucoma laser treatments
5














































.png)


